Other ways to give

Not into running marathons or climbing Everest? No problem; there are plenty of other ways you can support Ataxia UK!

Remembering a loved one Read more

Remember Ataxia UK in your Will, and help secure our future research and support Read more

The Big Christmas Challenge 2019 resources

After the huge success of the Big Give Christmas Challenge in 2018, will you join again to improve access to ataxia specialist care across the country?
The UK's first Ataxia Centre for Children!

Thanks to your generous giving to the Big Give last year, we are ecstatic to announce the first Ataxia Specialist Centre for children
Minoryx Therapeutics granted FDA Orphan Drug Designation in Friedreich’s Ataxia for new drug leriglitazone

Minoryx Therapeutics has announced that its lead drug candidate, leriglitazone (MIN-102), has been given an Orphan Drug Designation for Friedreich’s Ataxia by the US Food and Drug Administration (FDA).
DWP consultations to ask disabled people how the social security system could better support their needs